Durable Response | List of Frontiers open access articles

Case Report

Published on 02 May 2016

Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR

in Cancer Molecular Targets and Therapeutics

Tamara Aleksic
Lisa Browning
Martha Woodward
Rachel Phillips
Suzanne Page
Shirley Henderson
Nicholas Athanasou
Olaf Ansorge
Duncan Whitwell
Sarah Pratap

Frontiers in Oncology

doi 10.3389/fonc.2016.00098

5,498 views
35 citations

Case Report

Published on 03 Jul 2024

Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor

in Cancer Immunity and Immunotherapy

Angelo Luciano
Erica Pietroluongo
Margaret Ottaviano
Angela Grieco
Annarita Peddio
Pietro De Placido
Alberto Servetto
Massimo Mascolo
Silvia Varricchio
Roberto Bianco

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423800

3,723 views
3 citations

Case Report

Published on 28 Apr 2023

Case report: Durable response to ruxolitinib in a child with TREX1-related disorder

in Pediatric Rheumatology

Yasir Bin Khathlan
Sajdi Almutairi
Fahad B. Albadr
Abdullah A. Alangari
Abdulrahman Alsultan

Frontiers in Pediatrics

doi 10.3389/fped.2023.1178919

3,224 views
1 citation

Case Report

Published on 16 Dec 2021

Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Tin-Yun Tang
Katherine Daunov
Richard T. Lee

Frontiers in Oncology

doi 10.3389/fonc.2021.780798

2,452 views
3 citations

Case Report

Published on 23 Aug 2024

Durable response to pembrolizumab in hepatic metastasis from colonic carcinoma with Lynch syndrome: a case report

in Cancer Immunity and Immunotherapy

Cheng Xue
Dongqing Zhu
Xin Wang
Lina Jiao
Yunhui Lu
Sanli Zhang
Jiayi Lv
Linlin Cui
Mengna Ruan
Dechao Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455907

4,164 views
2 citations

Case Report

Published on 20 Sep 2021

Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer

in Molecular and Cellular Oncology

Fara Brasó-Maristany
Miriam Sansó
Nuria Chic
Débora Martínez
Blanca González-Farré
Esther Sanfeliu
Lucio Ghiglione
Esther Carcelero
Javier Garcia-Corbacho
Marcelo Sánchez

Frontiers in Oncology

doi 10.3389/fonc.2021.710596

7,894 views
7 citations

Perspective

Published on 18 Jan 2024

Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides

in Dermatology

Larisa Geskin
Christiane Querfeld
Emmilia Hodak
Neda Nikbakht
Evangelia Papadavid
Marco Ardigò
Ulrike Wehkamp
Martine Bagot

Frontiers in Medicine

doi 10.3389/fmed.2023.1298988

2,770 views
4 citations

Case Report

Published on 15 Dec 2022

Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma

in Cancer Immunity and Immunotherapy

Chien-Hsiang Kao
Chien-Ting Liu
Hao Lin
Yung-Cheng Huang
Jui Lan
Yu-Che Ou
Hung-Chun Fu
Chen-Hsuan Wu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1079253

3,698 views
7 citations

Case Report

Published on 11 Aug 2022

Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin

in Cancer Molecular Targets and Therapeutics

Chien-Yu Lin
Sheng-Huan Wei
Yi-Lin Chen
Chung-Ta Lee
Shang-Yin Wu
Chung-Liang Ho
Dean C. Pavlick
Po-Lan Su
Chien-Chung Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.919123

3,791 views
4 citations

Case Report

Published on 13 Sep 2022

Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Anna Kornietskaya
Sevindzh Evdokimova
Andrei Kachmazov
Alexander. Fedenko
Larisa Bolotina
Dmitriy Sidorov
Nadezhda Volchenko
Natalia Goeva
Anastasia Govaleshko
Andrey Kaprin

Frontiers in Oncology

doi 10.3389/fonc.2022.970142

4,665 views
12 citations

Case Report

Published on 09 Oct 2025

Case Report: Severe neutropenia induced by avelumab in a patient with Merkel cell carcinoma

in Cancer Immunity and Immunotherapy

Eri Ohta
Kayo Yamamoto
Hitomi Fujimura
Natsuko Saito-Sasaki
Etsuko Okada
Yu Sawada

Frontiers in Immunology

doi 10.3389/fimmu.2025.1672282

1,313 views
1 citation

Case Report

Published on 24 Apr 2025

Case Report: Two cases of chemotherapy refractory aggressive variant prostate cancer with extreme durable response to PARP inhibitor

in Genitourinary Oncology

Bohao Jiang
Yifan Bi
Yiming Chen
Jianbin Bi
Jian Deng
Gejun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1533627

3,065 views
1 citation

Case Report

Published on 20 May 2021

Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report

in Cancer Immunity and Immunotherapy

Zhilin Luo
Hong Zhang
Yajie Xiao
Rui Wang
Liping Zhang
Chenglu Huang
Yu Cao
Chao Sun
Yongtian Zhao
Hanqing Lin

Frontiers in Oncology

doi 10.3389/fonc.2021.633446

4,111 views
9 citations

Brief Research Report

Published on 23 May 2023

Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations

in Cell Death and Survival

Anna Ferrari
Delia Cangini
Andrea Ghelli Luserna di Rorà
Annalisa Condorelli
Marta Pugliese
Giovanni Schininà
Sebastiano Cosentino
Eugenio Fonzi
Chiara Domizio
Giorgia Simonetti

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2023.1165308

6,501 views
4 citations

Original Research

Published on 26 Jun 2023

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Lizhong Ding
Lu Sun
Melissa T. Bu
Yanjun Zhang
Lauren N. Scott
Robert M. Prins
Maureen A. Su
Melissa G. Lechner
Willy Hugo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1176994

11,086 views
24 citations

Case Report

Published on 06 Feb 2026

Long-term durable response to Sintilimab therapy in synchronous lung squamous cell carcinoma and gastric adenocarcinoma: a rare case report

in Pharmacology of Anti-Cancer Drugs

Margaret Mekuriya Bassaye
Zou Jijian
Zhou Li
Shuai Han

Frontiers in Oncology

doi 10.3389/fonc.2026.1679799

478 views

Articles

Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR

Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor

Case report: Durable response to ruxolitinib in a child with TREX1-related disorder

Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma

Durable response to pembrolizumab in hepatic metastasis from colonic carcinoma with Lynch syndrome: a case report

Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer

Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides

Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma

Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin

Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report

Case Report: Severe neutropenia induced by avelumab in a patient with Merkel cell carcinoma

Case Report: Two cases of chemotherapy refractory aggressive variant prostate cancer with extreme durable response to PARP inhibitor

Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report

Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

Long-term durable response to Sintilimab therapy in synchronous lung squamous cell carcinoma and gastric adenocarcinoma: a rare case report